Evidence map›Paper›PMID 26808318›Full record

SynthesisPloS one2016

Effect of Marine-Derived n-3 Polyunsaturated Fatty Acids on Major Eicosanoids: A Systematic Review and Meta-Analysis from 18 Randomized Controlled Trials.

Jiajing Jiang, Kelei Li, Fenglei Wang, Bo Yang, Yuanqing Fu, Jusheng Zheng, Duo Li

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Effect ofJournal of nutritional science
    Pooled it
  2. Trial
  3. Trial
  4. Effects of fish oil supplementation on eicosanoid production in patients at higher risk for colorectal cancer.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2019
    Trial
  5. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Lipid metabolism and rheumatoid arthritis.Frontiers in immunology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Functional Lipids in Autoimmune Inflammatory Diseases.International journal of molecular sciences · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jiajing JiangDepartment of Food Science and Nutrition, Zhejiang University, Hangzhou, China.
Kelei LiDepartment of Food Science and Nutrition, Zhejiang University, Hangzhou, China.
Fenglei WangDepartment of Food Science and Nutrition, Zhejiang University, Hangzhou, China.
Bo YangDepartment of Food Science and Nutrition, Zhejiang University, Hangzhou, China.
Yuanqing FuDepartment of Food Science and Nutrition, Zhejiang University, Hangzhou, China.
Jusheng ZhengDepartment of Food Science and Nutrition, Zhejiang University, Hangzhou, China.
Duo LiDepartment of Food Science and Nutrition, Zhejiang University, Hangzhou, China.
Zhejiang University · CNDeleted Institution

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMarine-derived n-3 polyunsaturated fatty acids (PUFA) may have a beneficial effect on inflammation via lowering pro-inflammatory eicosanoid concentrations. We aimed to assess the effect of marine-derived n-3 PUFA on prostaglandin E2 (PGE2), thromboxane B2 (TXB2), and leukotriene B4 (LTB4) through systematic review and meta-analysis of randomized controlled trials. METHOD AND

findingsA structured search strategy on PubMed, Web of Science and Cochrane up to November 2015 was undertaken in this meta-analysis. Standard mean difference was used to calculate the effect size of marine-derived n-3 PUFA on PGE2, TXB2 and LTB4 in a random-effect model. A total of 18 RCTs with 826 subjects were included in this systematic review and meta-analysis. Supplementation of marine-derived n-3 PUFA significantly decreased concentrations of TXB2 in serum/plasma in subjects with high risk of cardiovascular diseases (SMD:-1.26; 95% CI: -1.65, -0.86) and LTB4 in neutrophils in unhealthy subjects (subjects with non-autoimmune chronic diseases or auto-immune diseases) (SMD:-0.59: 95% CI: -1.02, -0.16). Subgroup analyses showed a significant reduction of LTB4 in subjects with rheumatoid arthritis (SMD: -0.83; 95% CI: -1.37, -0.29), but not in non-autoimmune chronic disease patients (SMD: -0.33; 95% CI: -0.97, 0.31). No significant publication bias was shown in the meta-analysis.

conclusionsMarine-derived n-3 PUFA had a beneficial effect on reducing the concentration of TXB2 in blood of subjects with high risk of CVD as well as LTB4 in neutrophils in unhealthy subjects, and that subjects with RA showed lower LTB4 content with supplementation of marine-derived n-3 PUFA.

Indexed as

Randomized Controlled Trials as TopicAnti-Inflammatory AgentsArthritis, RheumatoidChronic DiseaseDietary SupplementsDinoprostoneDose-Response Relationship, DrugEicosanoidsFatty Acids, Omega-3Fish OilsHumansLeukotriene B4Research DesignThromboxane B2Treatment OutcomeAnti-Inflammatory AgentsDinoprostoneEicosanoidsFatty Acids, Omega-3Fish OilsLeukotriene B4Thromboxane B2

Identifiers

PMID26808318
PMCPMC4726565
OpenAlexW2264702236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.